Alvine Hopes To Bring The First Celiac Drug To Market With New Partner AbbVie
This article was originally published in The Pink Sheet Daily
Executive Summary
Alvine and AbbVie have inked a deal that could allow the larger company to acquire the biotech based on results of a Phase IIb trial for its celiac disease treatment.